Edwards Lifesciences Earnings Estimate
EW Stock | USD 95.56 0.41 0.43% |
Edwards |
Edwards Lifesciences Earnings Estimation Breakdown
The calculation of Edwards Lifesciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Edwards Lifesciences is estimated to be 0.64 with the future projection ranging from a low of 0.63 to a high of 0.66. Please be aware that this consensus of annual earnings estimates for Edwards Lifesciences Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.63 Lowest | Expected EPS | 0.66 Highest |
Edwards Lifesciences Earnings Projection Consensus
Suppose the current estimates of Edwards Lifesciences' value are higher than the current market price of the Edwards Lifesciences stock. In this case, investors may conclude that Edwards Lifesciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Edwards Lifesciences' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2024 | Current EPS (TTM) | |
21 | 98.42% | 0.64 | 0.64 | 2.31 |
Edwards Lifesciences Earnings History
Earnings estimate consensus by Edwards Lifesciences Corp analysts from Wall Street is used by the market to judge Edwards Lifesciences' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Edwards Lifesciences' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Edwards Lifesciences Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences Earnings per Share Projection vs Actual
Actual Earning per Share of Edwards Lifesciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Edwards Lifesciences Corp predict the company's earnings will be in the future. The higher the earnings per share of Edwards Lifesciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Edwards Lifesciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Edwards Lifesciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Edwards Lifesciences should always be considered in relation to other companies to make a more educated investment decision.Edwards Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Edwards Lifesciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-02-06 | 2023-12-31 | 0.64 | 0.64 | 0.0 | 0 | ||
2023-10-25 | 2023-09-30 | 0.59 | 0.59 | 0.0 | 0 | ||
2023-07-26 | 2023-06-30 | 0.65 | 0.66 | 0.01 | 1 | ||
2023-04-26 | 2023-03-31 | 0.61 | 0.62 | 0.01 | 1 | ||
2023-01-31 | 2022-12-31 | 0.61 | 0.64 | 0.03 | 4 | ||
2022-10-27 | 2022-09-30 | 0.62 | 0.61 | -0.01 | 1 | ||
2022-07-28 | 2022-06-30 | 0.64 | 0.63 | -0.01 | 1 | ||
2022-04-26 | 2022-03-31 | 0.57 | 0.6 | 0.03 | 5 | ||
2022-01-26 | 2021-12-31 | 0.55 | 0.51 | -0.04 | 7 | ||
2021-10-27 | 2021-09-30 | 0.53 | 0.54 | 0.01 | 1 | ||
2021-07-29 | 2021-06-30 | 0.56 | 0.64 | 0.08 | 14 | ||
2021-04-20 | 2021-03-31 | 0.47 | 0.54 | 0.07 | 14 | ||
2021-01-27 | 2020-12-31 | 0.53 | 0.5 | -0.03 | 5 | ||
2020-10-21 | 2020-09-30 | 0.44 | 0.51 | 0.07 | 15 | ||
2020-07-23 | 2020-06-30 | 0.17 | 0.34 | 0.17 | 100 | ||
2020-04-23 | 2020-03-31 | 0.44 | 0.5 | 0.06 | 13 | ||
2020-01-30 | 2019-12-31 | 0.5 | 0.49 | -0.01 | 2 | ||
2019-10-23 | 2019-09-30 | 0.41 | 0.47 | 0.06 | 14 | ||
2019-07-23 | 2019-06-30 | 0.44 | 0.46 | 0.02 | 4 | ||
2019-04-23 | 2019-03-31 | 0.41 | 0.44 | 0.03 | 7 | ||
2019-01-31 | 2018-12-31 | 0.39 | 0.39 | 0.0 | 0 | ||
2018-10-23 | 2018-09-30 | 0.34 | 0.36 | 0.02 | 5 | ||
2018-07-26 | 2018-06-30 | 0.38 | 0.41 | 0.03 | 7 | ||
2018-04-24 | 2018-03-31 | 0.37 | 0.41 | 0.04 | 10 | ||
2018-02-01 | 2017-12-31 | 0.3 | 0.31 | 0.01 | 3 | ||
2017-10-24 | 2017-09-30 | 0.29 | 0.28 | -0.01 | 3 | ||
2017-07-26 | 2017-06-30 | 0.29 | 0.32 | 0.03 | 10 | ||
2017-04-25 | 2017-03-31 | 0.27 | 0.31 | 0.04 | 14 | ||
2017-02-01 | 2016-12-31 | 0.24 | 0.25 | 0.01 | 4 | ||
2016-10-25 | 2016-09-30 | 0.23 | 0.23 | 0.0 | 0 | ||
2016-07-26 | 2016-06-30 | 0.23 | 0.25 | 0.02 | 8 | ||
2016-04-26 | 2016-03-31 | 0.22 | 0.24 | 0.02 | 9 | ||
2016-02-02 | 2015-12-31 | 0.21 | 0.21 | 0.0 | 0 | ||
2015-10-26 | 2015-09-30 | 0.16 | 0.18 | 0.02 | 12 | ||
2015-07-28 | 2015-06-30 | 0.18 | 0.19 | 0.01 | 5 | ||
2015-04-23 | 2015-03-31 | 0.17 | 0.19 | 0.02 | 11 | ||
2015-02-03 | 2014-12-31 | 0.16 | 0.18 | 0.02 | 12 | ||
2014-10-23 | 2014-09-30 | 0.12 | 0.13 | 0.01 | 8 | ||
2014-07-29 | 2014-06-30 | 0.13 | 0.15 | 0.02 | 15 | ||
2014-04-24 | 2014-03-31 | 0.12 | 0.13 | 0.01 | 8 | ||
2014-02-03 | 2013-12-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2013-10-28 | 2013-09-30 | 0.11 | 0.11 | 0.0 | 0 | ||
2013-07-25 | 2013-06-30 | 0.13 | 0.14 | 0.01 | 7 | ||
2013-04-23 | 2013-03-31 | 0.13 | 0.12 | -0.01 | 7 | ||
2013-02-04 | 2012-12-31 | 0.13 | 0.15 | 0.02 | 15 | ||
2012-10-19 | 2012-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2012-07-24 | 2012-06-30 | 0.11 | 0.11 | 0.0 | 0 | ||
2012-04-24 | 2012-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2012-02-02 | 2011-12-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2011-10-19 | 2011-09-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2011-07-21 | 2011-06-30 | 0.08 | 0.08 | 0.0 | 0 | ||
2011-04-20 | 2011-03-31 | 0.07 | 0.09 | 0.02 | 28 | ||
2011-02-02 | 2010-12-31 | 0.09 | 0.09 | 0.0 | 0 | ||
2010-10-25 | 2010-09-30 | 0.07 | 0.07 | 0.0 | 0 | ||
2010-07-21 | 2010-06-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2010-04-20 | 2010-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2010-02-04 | 2009-12-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2009-10-21 | 2009-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
2009-07-20 | 2009-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2009-04-27 | 2009-03-31 | 0.06 | 0.06 | 0.0 | 0 | ||
2009-02-03 | 2008-12-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2008-10-21 | 2008-09-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2008-07-22 | 2008-06-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2008-04-22 | 2008-03-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2008-02-05 | 2007-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2007-10-22 | 2007-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2007-07-23 | 2007-06-30 | 0.05 | 0.05 | 0.0 | 0 | ||
2007-04-23 | 2007-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
2007-02-05 | 2006-12-31 | 0.04 | 0.05 | 0.01 | 25 | ||
2006-10-19 | 2006-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2006-07-24 | 2006-06-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2006-04-20 | 2006-03-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2006-02-02 | 2005-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2005-10-25 | 2005-09-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2005-07-21 | 2005-06-30 | 0.04 | 0.04 | 0.0 | 0 | ||
2005-04-21 | 2005-03-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2005-01-27 | 2004-12-31 | 0.04 | 0.04 | 0.0 | 0 | ||
2004-10-21 | 2004-09-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2004-07-27 | 2004-06-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2004-04-22 | 2004-03-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2004-02-03 | 2003-12-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2003-10-20 | 2003-09-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2003-07-22 | 2003-06-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2003-04-22 | 2003-03-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2003-02-03 | 2002-12-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2002-10-22 | 2002-09-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2002-07-23 | 2002-06-30 | 0.03 | 0.03 | 0.0 | 0 | ||
2002-04-23 | 2002-03-31 | 0.03 | 0.03 | 0.0 | 0 | ||
2002-02-05 | 2001-12-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-10-25 | 2001-09-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-07-26 | 2001-06-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-04-26 | 2001-03-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2001-02-06 | 2000-12-31 | 0.02 | 0.02 | 0.0 | 0 | ||
2000-10-31 | 2000-09-30 | 0.02 | 0.02 | 0.0 | 0 | ||
2000-08-24 | 2000-06-30 | 0.01 | 0.01 | 0.0 | 0 |
About Edwards Lifesciences Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Edwards Lifesciences earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Edwards Lifesciences estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Edwards Lifesciences fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Last Reported | Projected for 2024 | ||
Retained Earnings | 9 B | 9.4 B | |
Retained Earnings Total Equity | 8.7 B | 9.2 B | |
Price Earnings Ratio | 32.99 | 31.34 | |
Price Earnings To Growth Ratio | (5.41) | (5.14) |
Edwards Lifesciences Investors Sentiment
The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.
Pair Trading with Edwards Lifesciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Edwards Stock
0.89 | BSX | Boston Scientific Corp Financial Report 24th of April 2024 | PairCorr |
0.68 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
Moving against Edwards Stock
0.86 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.81 | PHG | Koninklijke Philips Financial Report 22nd of April 2024 | PairCorr |
0.73 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
0.71 | PIIIW | P3 Health Partners | PairCorr |
0.69 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.31 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.